In conclusion, the study indicated that BA could ameliorate RILI by inhibiting the CysLTs/CysLT1 signaling pathway, thereby alleviating IR-induced pulmonary inflammation and pulmonary fibrosis. Here, CYSLTR1 is linked to pulmonary fibrosis.